RED+BLUE STRATEGIES for EXPRESS SCRIPTS INC.

Health Issues HCR

Implementation of the Health Reform Law with a focus on regulations related to the medical loss ratio (MLR), Accountable Care Organizations, Transparency, E-prescribing, Health Information Technology, and Essential Health Benefits. Reauthorization of the Prescription Drug User Fee Act, specifically issues related to track and trace policies and exclusivity. Issues related to pathways for biogenerics in both domestic and international arenas. Proposed OPM-focused policies in the Administration's 2013 Budget related to the utilization of Pharmacy Benefit Managers.

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

H.R. 3630 (S. Amdt 1465) Temporary Payroll Tax Cut Continuation Act of 2011-12 - Tracking Medicare offsets Monitoring ongoing Medicare and Medicaid regulations and guidance related to prescription medications, PBMs and related entities. Monitoring potential health-related offsets being considered as part of the deficit reduction package related to Medicare Part D and Medicaid pharmacy benefits.

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Executive Office of the President (EOP)

Bills named: H.R. 3630 (112th)

Pharmacy PHA

H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which creates and antitrust exemption for certain pharmacies. Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy. Issues impacting PBMs included in the Prescription Drug User Fee Act reauthorization and the Generic Drug User Fee Reauthorization

Contacted: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1946 (112th)